Severe combined immunodeficiency resulting from mutations in MTHFD1.

Area of Science:

• Biochemistry
• Immunology
• Genetics

Background:

• Folate and vitamin B12 metabolism are crucial for purine synthesis.
• Defects in these pathways are linked to immunodeficiency disorders.
• Severe combined immunodeficiency (SCID) presents with profound immune system dysfunction.

Observation:

• A patient presented with SCID, megaloblastic anemia, leukopenia, atypical hemolytic uremic syndrome, and neurologic issues.
• Hydroxocobalamin and folate therapy led to partial immune reconstitution.
• Whole exome sequencing revealed compound heterozygous mutations in the MTHFD1 gene.

Findings:

• MTHFD1 encodes a trifunctional protein vital for single-carbon folate derivative processing.
• This represents a novel genetic cause of SCID.
• The study details the immunologic profile and response to metabolic therapy.

Implications:

• This discovery broadens the spectrum of known metabolic causes for SCID.
• It highlights MTHFD1 mutations as an important diagnostic consideration.
• Targeted metabolic supplementation shows therapeutic potential for this SCID subtype.